Endometriosis and proteolytic enzymes.
Endometriosis has been treated as a hormonal condition for decades, and the standard hormonal interventions leave a lot of people no better off than they started. The more recent evidence points at the immune and inflammatory drivers alongside the hormonal ones, and the protocol that reflects that shift looks different from the standard one.
Part 1. Why endometriosis is not simply a hormonal problem.
The textbook story treats endometriosis as tissue similar to the uterine lining growing outside the uterus, driven and responsive to oestrogen. That story is not wrong, but it is incomplete, and treating a chronic condition with an incomplete model of it is why hormonal suppression works for some women and does nothing for others.
The more current picture, drawn from immunology and inflammation research over the past decade, is that endometriosis behaves like an inflammatory and immune-mediated condition with hormonal components. The endometriotic lesions themselves produce inflammatory cytokines. The pain associated with the condition correlates more closely with local inflammation than with lesion size. The immune system's ability to clear ectopic endometrial cells is impaired in women with the condition, which is why the cells persist and proliferate in the first place. And gut health shows up as a repeatedly named factor in immune modulation, which is where the practice's gut-first approach starts earning its place.
None of this replaces the hormonal picture, and none of it is a licence to skip diagnosis or specialist care. It sits alongside them and explains why the standard interventions land differently on different women. A protocol that addresses the inflammation and the immune modulation, alongside whatever hormonal work is being done by a gynaecologist, is what the more recent literature actually supports.
Part 1 draft to be extended with Maria's preferred inflammatory-marker panel (CRP, ferritin, cytokine markers), the specific literature she references, and any case-file numbers or symptom-reduction data she is comfortable publishing.
Part 2. The proteolytic-enzyme protocol structure.
Proteolytic enzymes are a category that includes bromelain, papain, serrapeptase, nattokinase and several others. They break down protein-based inflammatory mediators, disrupt the fibrin matrix that endometriotic lesions build around themselves, and support the immune system's clearance work that would otherwise be blocked. The evidence base for their use in endometriosis is smaller than the hormonal literature but consistent and growing, and the clinical experience in Maria's practice matches what the research suggests.
The protocol structure is not "take enzymes and hope." It sits inside a broader engagement that addresses gut function first, layers in dietary changes that reduce the inflammatory load the body is already carrying, and only then introduces the enzyme work at doses and timings tailored to the individual. The typical trajectory is measurable over three to six months: pain scores drop, cycle regularity improves, energy stabilises, and inflammatory markers on blood panels come down.
The protocol does not replace a gynaecologist. It runs alongside whatever hormonal, surgical or medical work a specialist is doing, and clients are always encouraged to keep that specialist relationship active.
Part 2 draft to be extended with Maria's specific enzyme protocol structure, dosing rationale, typical duration, and how she measures progress. Also confirm what she wants to say about the recent revision to her own treatment protocol referenced in the original blog post.
Working with an endometriosis diagnosis?